Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 24, 2014 08:05 ET | Source: MYOS Corporation

MYOS Corporation Receives Notice of Allowance of U.S. Patent Application for Proprietary Manufacturing Methods of Fortetropin

- Patent will protect MYOS' intellectual property portfolio for Fortetropin through 2033 – - Key patent highlights the innovation underlying MYOS' novel myostatin inhibitor technology and...